Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Umbrella Labs is a specialized supplier of high-purity research chemicals, primarily focusing on Selective Androgen Receptor Modulators (SARMs), peptides, and nootropics. The company provides analytical-grade compounds to the scientific research community and the biohacking industry, emphasizing quality through rigorous third-party laboratory testing. Their product portfolio includes well-known research agents such as RAD-140, MK-677, and LGD-4033, which are utilized in studies concerning muscle wasting, metabolic health, and endocrinology. While their offerings are strictly marketed for laboratory research use and not for human consumption, Umbrella Labs has established itself as a key vendor in the experimental life sciences market. The company operates primarily through an e-commerce model, providing detailed Certificates of Analysis to ensure compound identity and purity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Umbrella Labs.